MD4232C1 - Medicament based on troxerutin and carbazochrome for the treatment of progressive hepatic cirrhosis associated with heart failure - Google Patents

Medicament based on troxerutin and carbazochrome for the treatment of progressive hepatic cirrhosis associated with heart failure

Info

Publication number
MD4232C1
MD4232C1 MDA20120103A MD20120103A MD4232C1 MD 4232 C1 MD4232 C1 MD 4232C1 MD A20120103 A MDA20120103 A MD A20120103A MD 20120103 A MD20120103 A MD 20120103A MD 4232 C1 MD4232 C1 MD 4232C1
Authority
MD
Moldova
Prior art keywords
treatment
heart failure
carbazochrome
troxerutin
hepatic cirrhosis
Prior art date
Application number
MDA20120103A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD4232B1 (en
Inventor
Георге АНГЕЛИЧ
Олег КРУДУ
Ульвия МАММАДОВА
Original Assignee
Георге АНГЕЛИЧ
Олег КРУДУ
Ульвия МАММАДОВА
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Георге АНГЕЛИЧ, Олег КРУДУ, Ульвия МАММАДОВА filed Critical Георге АНГЕЛИЧ
Priority to MDA20120103A priority Critical patent/MD4232C1/en
Publication of MD4232B1 publication Critical patent/MD4232B1/en
Publication of MD4232C1 publication Critical patent/MD4232C1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to medicine, particularly to hepatology and can be used for the treatment of progressive hepatic cirrhosis associated with heart failure.Summary of the invention consists in that a medicament is used on the basis of troxerutin and carbazochrome, in a dose of 300 mg and, respectively, 3 mg, for the treatment of progressive hepatic cirrhosis associated with heart failure. At the same time, the medicament is administered 1 tablet, 2…3 times daily, per os, during 14…30 days.
MDA20120103A 2012-11-08 2012-11-08 Medicament based on troxerutin and carbazochrome for the treatment of progressive hepatic cirrhosis associated with heart failure MD4232C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20120103A MD4232C1 (en) 2012-11-08 2012-11-08 Medicament based on troxerutin and carbazochrome for the treatment of progressive hepatic cirrhosis associated with heart failure

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20120103A MD4232C1 (en) 2012-11-08 2012-11-08 Medicament based on troxerutin and carbazochrome for the treatment of progressive hepatic cirrhosis associated with heart failure

Publications (2)

Publication Number Publication Date
MD4232B1 MD4232B1 (en) 2013-06-30
MD4232C1 true MD4232C1 (en) 2014-01-31

Family

ID=48749683

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20120103A MD4232C1 (en) 2012-11-08 2012-11-08 Medicament based on troxerutin and carbazochrome for the treatment of progressive hepatic cirrhosis associated with heart failure

Country Status (1)

Country Link
MD (1) MD4232C1 (en)

Citations (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003864A1 (en) * 1984-03-01 1985-09-12 Casley Smith John Royle Treatment of high protein oedemas by direct application of benzo-pyrones
CH671021A5 (en) * 1987-05-07 1989-07-31 Espanola Prod Quimicos Prodn. of hydroxy:ethylated diosmin mixts. - useful for treating intoxication
FR2661610A1 (en) * 1990-05-02 1991-11-08 Rhone Poulenc Sante Novel lyophilised form of diosmin and its preparation
FR2668705A1 (en) * 1990-11-06 1992-05-07 Bouchara Sa Novel skin preparations having a phlebotonic action and process for preparing them
EP0541874A1 (en) * 1990-05-11 1993-05-19 Jérôme CORBIERE Compositions containing diosmin
FR2692145A1 (en) * 1992-06-10 1993-12-17 Bellon Labor Sa Roger Topical compsns. having a vascular protecting and veinotonic action - contain diosmin, fatty acid(s), hydrating agent, neutralising agent, gelling agent and opt. stabilisers, preservatives, colours, perfumes, etc.
JPH08301757A (en) * 1995-05-10 1996-11-19 Kureha Chem Ind Co Ltd Hsp47 synthesis suppressing agent
NZ280418A (en) * 1994-11-08 1997-03-24 Adir Diosmin composition; effervescent granule, in tablet or sachet form containing micronised diosmin
CA2287363A1 (en) * 1997-05-13 1998-11-19 Remacle, Jose Use of a pharmaceutical composition for treating and/or preventing ischemia
DE19922287A1 (en) * 1998-05-15 1999-11-25 Coletica Lyon Cosmetic, dermatological, pharmaceutical, dietetic or food compositions, e.g. for improving skin condition, comprise flavonoid esters
JP2000023635A (en) * 1998-07-10 2000-01-25 M P G Kk Granule nutrient auxiliary food
WO2000015237A1 (en) * 1998-09-15 2000-03-23 Korea Research Institute Of Bioscience And Biotechnology Composition containing rutin and quercetin for preventing or treating elevated blood lipid level-related diseases
KR20000019719A (en) * 1998-09-15 2000-04-15 박호군 Composition comprising diosmin for preventing and treating hyperlipidemia and arteriosclerosis
KR20010007624A (en) * 2000-10-06 2001-01-26 박호군 Composition for preventing and treating atherosclerosis, hyperlipidemia, hepatic diseases and glycosemia, comprising neohesperidin dihydrochalcone
KR20010007625A (en) * 2000-10-06 2001-01-26 박호군 Composition for preventing and treating atherosclerosis and hyperlipidemia, comprising diosmin
WO2002020030A2 (en) * 2000-09-11 2002-03-14 Michael D Stander Use of buchu extracts for hypertension
WO2004032942A1 (en) * 2002-10-11 2004-04-22 Laboratoires Innothera Sas Dry oral phlebotonic and vasculoprotective formulation for the treatment of venous insufficiency, capillary fragility and haemorrhoids, in the pharmaceutical form of a chewable tablet containing diosmin
FR2857665A1 (en) * 2003-07-16 2005-01-21 Centre Nat Rech Scient New 3-halo flavone derivatives useful for treating disorders involving an excess of oxidizing species, e.g. cancer, ischemic diseases, dermatosis, neurodegenerative diseases, inflammatory diseases
US20060040911A1 (en) * 2003-01-06 2006-02-23 Liao Benedict S Method for preventing and/or treating the cardiovascular and hepatic diseases induced by hyperlipidemia which comprises administered an effective amount of bioflavonoids extract derived from fructus crataegus (lipid metabolism and fructus crataegus)
CN1823807A (en) * 2006-01-11 2006-08-30 刘展欣 Micronize diosmin and hesperidine composition suppository
EP1707192A2 (en) * 2005-03-30 2006-10-04 Therapicon Srl Pharmaceutical composition
MX2007011002A (en) * 2007-09-07 2009-03-09 World Trade Imp Export Wtie Ag Pharmaceutical composition combining various venotonic and vasoprotective agents for the treatment of chronic venous insufficiency.
MD3987C2 (en) * 2009-09-03 2010-07-31 Георге АНГЕЛИЧ Use of Diosmine for the treatment of advancing hepatic cirrhosis associated with cardiac insufficiency

Patent Citations (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003864A1 (en) * 1984-03-01 1985-09-12 Casley Smith John Royle Treatment of high protein oedemas by direct application of benzo-pyrones
CH671021A5 (en) * 1987-05-07 1989-07-31 Espanola Prod Quimicos Prodn. of hydroxy:ethylated diosmin mixts. - useful for treating intoxication
FR2661610A1 (en) * 1990-05-02 1991-11-08 Rhone Poulenc Sante Novel lyophilised form of diosmin and its preparation
EP0541874A1 (en) * 1990-05-11 1993-05-19 Jérôme CORBIERE Compositions containing diosmin
FR2668705A1 (en) * 1990-11-06 1992-05-07 Bouchara Sa Novel skin preparations having a phlebotonic action and process for preparing them
FR2692145A1 (en) * 1992-06-10 1993-12-17 Bellon Labor Sa Roger Topical compsns. having a vascular protecting and veinotonic action - contain diosmin, fatty acid(s), hydrating agent, neutralising agent, gelling agent and opt. stabilisers, preservatives, colours, perfumes, etc.
FR2692145B1 (en) * 1992-06-10 1995-05-05 Bellon Labor Sa Roger New composition for topical use containing diosmin.
NZ280418A (en) * 1994-11-08 1997-03-24 Adir Diosmin composition; effervescent granule, in tablet or sachet form containing micronised diosmin
JPH08301757A (en) * 1995-05-10 1996-11-19 Kureha Chem Ind Co Ltd Hsp47 synthesis suppressing agent
CA2287363A1 (en) * 1997-05-13 1998-11-19 Remacle, Jose Use of a pharmaceutical composition for treating and/or preventing ischemia
DE19922287A1 (en) * 1998-05-15 1999-11-25 Coletica Lyon Cosmetic, dermatological, pharmaceutical, dietetic or food compositions, e.g. for improving skin condition, comprise flavonoid esters
JP2000023635A (en) * 1998-07-10 2000-01-25 M P G Kk Granule nutrient auxiliary food
WO2000015237A1 (en) * 1998-09-15 2000-03-23 Korea Research Institute Of Bioscience And Biotechnology Composition containing rutin and quercetin for preventing or treating elevated blood lipid level-related diseases
KR20000019719A (en) * 1998-09-15 2000-04-15 박호군 Composition comprising diosmin for preventing and treating hyperlipidemia and arteriosclerosis
WO2002020030A2 (en) * 2000-09-11 2002-03-14 Michael D Stander Use of buchu extracts for hypertension
KR20010007624A (en) * 2000-10-06 2001-01-26 박호군 Composition for preventing and treating atherosclerosis, hyperlipidemia, hepatic diseases and glycosemia, comprising neohesperidin dihydrochalcone
KR20010007625A (en) * 2000-10-06 2001-01-26 박호군 Composition for preventing and treating atherosclerosis and hyperlipidemia, comprising diosmin
WO2004032942A1 (en) * 2002-10-11 2004-04-22 Laboratoires Innothera Sas Dry oral phlebotonic and vasculoprotective formulation for the treatment of venous insufficiency, capillary fragility and haemorrhoids, in the pharmaceutical form of a chewable tablet containing diosmin
US20060040911A1 (en) * 2003-01-06 2006-02-23 Liao Benedict S Method for preventing and/or treating the cardiovascular and hepatic diseases induced by hyperlipidemia which comprises administered an effective amount of bioflavonoids extract derived from fructus crataegus (lipid metabolism and fructus crataegus)
FR2857665A1 (en) * 2003-07-16 2005-01-21 Centre Nat Rech Scient New 3-halo flavone derivatives useful for treating disorders involving an excess of oxidizing species, e.g. cancer, ischemic diseases, dermatosis, neurodegenerative diseases, inflammatory diseases
EP1707192A2 (en) * 2005-03-30 2006-10-04 Therapicon Srl Pharmaceutical composition
CN1823807A (en) * 2006-01-11 2006-08-30 刘展欣 Micronize diosmin and hesperidine composition suppository
MX2007011002A (en) * 2007-09-07 2009-03-09 World Trade Imp Export Wtie Ag Pharmaceutical composition combining various venotonic and vasoprotective agents for the treatment of chronic venous insufficiency.
MD3987C2 (en) * 2009-09-03 2010-07-31 Георге АНГЕЛИЧ Use of Diosmine for the treatment of advancing hepatic cirrhosis associated with cardiac insufficiency

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Matcovschi C., Procopişin V., Parii B. Compendium Medicamentorum. Tipografia Centrală, Chişinău, 2001, p. 759 *

Also Published As

Publication number Publication date
MD4232B1 (en) 2013-06-30

Similar Documents

Publication Publication Date Title
MY159353A (en) Pirfenidone treatment for patients with atypical liver function
EA201401028A1 (en) PHARMACEUTICAL COMPOSITION, CONTAINING EMAGOGLIFLOZIN AND MEDICINES FOR OBESITY
PE20142319A1 (en) MULTIPLE SCLEROSIS TREATMENT WITH A COMBINATION OF LAQUINIMOD AND GLATIRAMER ACETATE
UA105191C2 (en) Treatment with pirfenidone of patients with abnormal liver function
JP2013155188A5 (en)
CL2014002935A1 (en) Method to treat a human patient with multiple sclerosis with laquinimod, at a daily dose of about 1.2mg; an oral unit dosage form of 1.2 mg of laquinimod and a carrier
MX2016011333A (en) Drug delivery systems and methods for treatment of bladder cancer with gemcitabine.
MX2016000220A (en) Regulation of glucose metabolism using anti-cgrp antibodies.
MX2016008027A (en) Use of laquinimod to delay huntington's disease progression.
MX2018011293A (en) Prolonged release pharmaceutical composition comprising cysteamine or salt thereof.
MD4232B1 (en) Medicament based on troxerutin and carbazochrome for the treatment of progressive hepatic cirrhosis associated with heart failure
MD4231C1 (en) Medicament based on troxerutin and carbazochrome for the treatment of portal gastropathies in hepatic cirrhosis
MD3987C2 (en) Use of Diosmine for the treatment of advancing hepatic cirrhosis associated with cardiac insufficiency
MX2016006375A (en) A combination of dosage units for use in the treatment of pre-term labour condition.
MD4458C1 (en) Use of Polybiolin drug in patients with liver cirrhosis
MD3986C2 (en) Use of Diosmine for the treatment of portal gastropathies in the hepatic cirrhosis
NZ600486A (en) Pirfenidone treatment for patients with atypical liver function
MX2011011879A (en) Use of betaxanthins and derivatives thereof for the preparation of a drug for the treatment of prediabetes and diabetes.
UA111312C2 (en) Treatment of acute coronary syndrome without st-segment elevation in patients with ischemic heart disease and metabolic syndrome following transcutaneous transluminar coronary angioplasty
Gola Various toxicities: 12 case reports
UA103788U (en) Method for treatment of acute coronary syndrome without st-segment elevation in patients with ischemic heart disease and metabolic syndrome following percutaneous transluminar coronary angioplasty
Kang Encephalopathy: 2 case reports
Schmalbach Citrates/rituximab
UA106056U (en) METHOD OF TREATMENT OF PATIENTS WITH PATIENTS WITH COMBINED METABOLIC SYNDROME AND INCREASED LEVEL OF INDICATORS OF SYSTEMIC INFLAMMATION
UA105586U (en) Method for treating hepatic encephalopathy

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)